Official Update! TEST & GO rules from 1 April 2022
Travellers will be allowed to enter the kingdom without the need to show proof of a negative RT-PCR test within 72 hours of travel. This information has been updated on 31 March, 2022. The following rules will be in effect from 1 April, 2022, and will also apply to travellers…
Thailand to lift pretravel testing requirement for international arrivals from 1 April 2022
Bangkok, 18 March, 2022 – Thailand’s Centre for COVID-19 Situation Administration (CCSA) today approved the lifting of the pretravel testing requirement for international arrivals beginning 1 April, 2022, as the kingdom prepares a four-phase plan to downgrade the COVID-19 pandemic to an endemic disease. TAT Newsroom will be providing updates in…
UPDATED! TEST & GO rules from 1 March 2022
Travellers can arrive in Thailand by air, land, and water with the required prepaid accommodation reduced to 1 night and the COVID-19 tests revised to 1 RT-PCR and 1 self-ATK. The health insurance coverage has also been reduced to no less than US$20,000. The following rules will be in effect…
UPDATED! TEST & GO rules to ease from 1 March 2022
Travellers can arrive in Thailand by air, land, and water with the required prepaid accommodation reduced to 1 night and the COVID-19 tests revised to 1 RT-PCR and 1 self-ATK. The following new rules will be in effect from 1 March, 2022 (travellers can enter into Thailand on 7 March,…
Indian Govt to take a call on restarting international flights from March 1 this week
Final nod to come from the health ministry. Scheduled international passenger flights have been banned in India from March 23, 2020. Special flights are operating between India and approximately 40 countries since July 2020 under air-bubble arrangements. An inter-ministerial committee of officials from the ministries of home affairs, health and…
Health Ministry to Add Sinovac-Pfizer Cross-Vaccine Option for Children Aged 12-17
A cross-vaccination approach using the Sinovac and Pfizer COVID-19 vaccines is now being developed as an option for recipients aged 12-17. The move comes in response to findings that this approach heightens immunity as effectively as two doses of only the Pfizer vaccine. The recommendation for cross-vaccination in teens was…